Skip to Content Facebook Feature Image

AZIMUT|BENETTI GROUP LEADS THE NAUTICAL WORLD FOR A QUARTER CENTURY

Business

AZIMUT|BENETTI GROUP LEADS THE NAUTICAL WORLD FOR A QUARTER CENTURY
Business

Business

AZIMUT|BENETTI GROUP LEADS THE NAUTICAL WORLD FOR A QUARTER CENTURY

2025-03-17 11:00 Last Updated At:11:25

Azimut|Benetti Group is the world's leading manufacturer of mega yachts for the twenty-fifth year, with a share of 20% of the global market.

HONG KONG, March 17, 2025 /PRNewswire/ -- Azimut|Benetti Group is number one in the production of mega yachts over 24 meters, leading the industry in the Global Order Book 2025, the annual ranking by the reference publication Boat International based on data from 185 shipyards on 5 continents.

"Twenty-five years at the top of the sector represent a true 'record within a record', a testament to our unwavering entrepreneurial vision which is based on an organic, resilient and sustainable growth strategy aimed at creating durable value that lasts over time. This is the privilege and the responsibility of a private family company," comments Giovanna Vitelli, Chair of Azimut|Benetti Group.

The Group tops all categories with 164 units under construction for a total of 5,905 meters, corresponding to 20% of the global market under examination by the Global Order Book. These data reflect the record results of the last financial year, which ended on August 31, 2024 with revenues of 1.3 billion euros and an order portfolio that extends to 2029.

Charting the course, the strategic guidelines that have driven 25 years of leadership:

  • product leadership,
  • quality at the heart of the production strategy,
  • widespread presence in global markets,
  • the best people and skills

Product leadership

The Azimut|Benetti Group boasts the world's widest range of yachts, with Azimut standing out in the 12 to 44-meter segment and Benetti offering mega and giga yachts from 34 to over 100, including full-custom projects.

Over the past 25 years, the Group has created innovative concepts thanks to a profound reinterpretation of onboard spaces: the Azimut Seadeck Series, the Benetti Oasis and Veranda Deck® embody the latest expressions of a contemporary lifestyle, representing true revolutions in the industry.

In terms of innovation, which today focuses on emission reduction, the Group's strategy is based on the implementation of the best available technologies to achieve significant results in the short term. Today, the Group stands out for its approach based on the integration of advanced naval architecture, hybrid technologies and HVO biofuel. Azimut is the only brand in the industry with a fleet where over half consists of Low Emission Yachts and that offers 4 levels of electrification (from Mild to Full Hybrid), and Benetti offers hybrid versions of almost its entire range. Currently, a total of 10 hybrid mega yachts are under construction at the Benetti shipyard. In the B.Yond line, among the 13 units sold, 7 are hybrids.

Both brands have created a range devoted to maximum reduction of CO2 emissions: the Seadeck Series by Azimut, which achieves -40% CO2 emissions over an average year of use, and B.Yond by Benetti, which achieves -24% CO2 emissions and -80% NOX.

Quality at the heart of the production strategy

The production philosophy of the Azimut|Benetti Group is based on two pillars: the internalization of crucial activities to guarantee the highest quality and the selection of the best supply chain partners.

To ensure oversight of steel processing for boats under 45 meters, the Group has established the Light Steel Hub in Tuscany. In 2025, this will be complemented by the Composite Hub, dedicated to fiberglass and carbon fiber, materials in which the Avigliana site has excelled in processing for decades. The production capacity of the Lusben division, dedicated to refit services also for large sailing ships, is also scheduled for expansion.

Widespread presence in global markets

The Group's market strategy has always stood out for its balanced distribution of business between the main markets: Europe, the United States and MEA-APAC. This approach allows for strategic management of the offering, while helping to mitigate local risk and reduce exposure to destabilizing factors.

For the best management of its clients, Azimut entrusts its presence in each territory and its relationships with owners to the most structured and widespread network of exclusive dealers in the nautical industry, with the sole exception of the direct boutiques in the most renowned world yachting locations. Benetti collaborates with the most prestigious broker houses, through its area managers worldwide.

The best people and skills

The Group boasts a strong sense of belonging among its people, who have the highest skills in the industry. The growth in size has encouraged the entry of new talents, with an increase of 18% in the last 6 years. In this phase of dimensional expansion, the company is committed to passing on its culture, values  and distinctive skills. 

To facilitate this, it has launched, among other initiatives, a Corporate Academy which favors the transmission of know-how to protect the wealth of knowledge and the bond between mentors and new generations, while the 'Nauticità' project (Seaworthiness project) invites employees to spend one or more days aboard a Group yacht to experience what inspires us every day: the passion for the sea.

www.azimutyachts.com 

WeChat: Azimut Yachts
Instagram: @azimut_yachts
Facebook: www.facebook.com/AzimutyachtsPage

www.benettiyachts.it 

WeChat: benettiofficial
Instagram: @benettiyachts
Facebook: www.facebook.com/Benettiyachts

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

AZIMUT|BENETTI GROUP LEADS THE NAUTICAL WORLD FOR A QUARTER CENTURY

AZIMUT|BENETTI GROUP LEADS THE NAUTICAL WORLD FOR A QUARTER CENTURY

AZIMUT|BENETTI GROUP LEADS THE NAUTICAL WORLD FOR A QUARTER CENTURY

AZIMUT|BENETTI GROUP LEADS THE NAUTICAL WORLD FOR A QUARTER CENTURY

T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors

Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer

Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.

"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."

Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.

 

 

To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.

Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.

"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."

About Alamar Biosciences, Inc. 
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Recommended Articles